Agility Robotics is set to go public through a merger with Churchill Capital XI, targeting a valuation of $2.5 billion. This makes it the first US-listed company focused solely on humanoid robotics, with its flagship robot Digit 5 designed for safety and modularity. The company aims to generate over $2 billion in recurring revenue by 2035, supported by partnerships with Nvidia and US regulatory protections. While promising, risks include execution challenges, capital burn, and regulatory uncertainties. The merger is expected to close on November 2nd pending shareholder approval.
Churchill Capital and its merger target Agility Robotics provide context for Pluang's Technology sector data. As of Oct 21, 2026 16:51 WIB, 94 of 150 priced Technology-sector US stocks rose and 46 fell. Notable movers include HPE at USD 58.13 with a 3.58% increase and 59% buy order activity, AXTI at USD 58.89 up 3.15% with 63% buy orders, and ZM at USD 100.45 rising 3.07% but with 100% sell orders. Typical hold times vary from 17 to 92 days among these stocks.
The Human Feedback Foundation, supported by RBC, has launched the Agentic AI Design Exchange, a national program aimed at helping Canadian nonprofits design, build, and deploy AI agents responsibly. Funded through RBC's Stronger Nonprofits Program, t...
Satellos Bioscience Inc., a clinical-stage company focused on treatments for degenerative muscle diseases, announced its management will participate in two investor conferences in November: the Guggenheim Healthcare Innovation Conference on Nov 9 in ...
YYForce Inc. has purchased 20 wearable data collection systems to gather real task data from hotel room service at Novotel Singapore. This project aims to record and analyze experienced staff performing tasks like bed-making, towel folding, and clean...
The global digital health and remote patient monitoring market is projected to grow from $26.8 billion in 2025 to $80.8 billion by 2031, at a compound annual growth rate of 20.2%. This growth is driven by increasing demand for chronic disease managem...
The global private credit and alternative lending market, valued at $2.31 trillion in 2026, is expected to grow at a 7.8% CAGR to reach $3.36 trillion by 2031. Recent liquidity pressures in 2025, triggered by bankruptcies and AI sector concerns, caus...
